SUPPLEMENT

Q2 2024 — Income statement trends

Q2 2024PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423 	Q124 	Q224
Revenues:
Clearing and transaction fees 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9
Market data and information services 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4 	175.0
Other Revenue 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6 	107.6
Total revenues 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,532.5
Expenses:
Compensation and benefits 	185.3 	189.6 	193.0 	204.5 	205.7 	205.5 	212.9 	206.0 	204.7
Technology 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4 	64.1
Professional fees and outside services 	32.0 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1 	34.7
Amortization of purchased intangibles 	57.1 	55.5 	56.7 	56.8 	57.0 	57.2 	55.6 	55.2 	55.5
Depreciation and amortization 	33.0 	34.5 	33.9 	31.9 	32.3 	31.1 	30.7 	30.1 	28.7
Licensing and other fee agreements 	83.1 	83.6 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9 	85.9
Other expense 	51.1 	43.9 	95.0 	60.4 	57.3 	56.5 	101.9 	56.6 	58.3
Operating expenses 	487.5 	489.0 	539.5 	527.9 	521.6 	517.6 	576.1 	528.3 	531.9
Operating Income 	749.7 	738.8 	668.3 	913.7 	838.6 	820.2 	863.2 	959.6 	1,000.6
Operating Margin 	61% 	60% 	55% 	63% 	62% 	61% 	60% 	64% 	65%
Non-operating Income and Expense
Investment income 	286.9 	686.2 	1,152.2 	1,357.7 	1,568.2 	1,272.5 	1,076.9 	1,071.3 	1,044.5
Interest and other borrowing costs 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1)
Equity in net gains (losses) of unconsolidated subsidiaries 	87.3 	76.5 	64.0 	78.2 	75.1 	76.8 	66.8 	87.2 	86.4
Other non-operating income (expense) 	(217.3) 	(581.1) 	(1,017.3) 	(1,152.8) 	(1,425.3) 	(1,155.6) 	(961.2) 	(964.8) 	(936.9)
Non-operating income (expense) 	117.0 	141.2 	159.0 	243.2 	177.8 	154.1 	142.8 	153.8 	153.9
Income before income taxes 	866.7 	880.0 	827.3 	1,156.9 	1,016.4 	974.3 	1,006.0 	1,113.4 	1,154.5
Income taxes 	204.2 	200.4 	189.4 	273.1 	238.8 	224.1 	191.4 	258.2 	271.3
Net income 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2 	883.2
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2 	883.2
Net Income Attributable to Common Shareholders of CME Group 	654.1 	671.1 	629.9 	872.7 	767.8 	740.8 	804.3 	844.4 	872.1
Effective Tax Rate 	23.6% 	22.8% 	22.8% 	23.6% 	23.5% 	23.0% 	19.0% 	23.2% 	23.2%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.82 	1.87 	1.76 	2.43 	2.14 	2.06 	2.24 	2.35 	2.43
Diluted EPS 	1.82 	1.87 	1.75 	2.43 	2.14 	2.06 	2.24 	2.35 	2.42
Weighted average number of common stock shares:
Basic Shares 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258 	359,330
Diluted Shares 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833 	359,869
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423 	Q124 	Q224
Revenues:
Clearing and transaction fees 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9
Market data and information services 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4 	175.0
Other Revenue 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6 	106.6
Total revenues 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,531.5
Expenses:
Compensation and benefits 	189.5 	189.1 	184.6 	192.8 	194.4 	193.5 	204.4 	196.1 	201.7
Technology 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4 	64.1
Professional fees and outside services 	31.4 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1 	34.7
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	32.9 	33.8 	33.9 	31.9 	31.8 	31.1 	29.8 	29.3 	28.7
Licensing and other fee agreements 	83.1 	81.9 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9 	85.9
Other expense 	59.6 	54.4 	84.5 	59.7 	56.2 	56.5 	80.3 	56.5 	58.6
Operating expenses 	442.4 	441.1 	463.9 	458.7 	451.7 	448.4 	489.5 	462.3 	473.7
Operating Income 	794.8 	786.7 	743.9 	982.9 	908.5 	889.4 	949.8 	1,025.6 	1,057.8
Operating Margin 	64% 	64% 	62% 	68% 	67% 	66% 	66% 	69% 	69%
Non-operating Income and Expense
Investment income 	299.5 	688.5 	1,147.1 	1,277.5 	1,564.0 	1,276.6 	1,068.5 	1,061.7 	1,033.0
Interest and other borrowing costs 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1)
Equity in net gains (losses) of unconsolidated subsidiaries 	98.2 	89.6 	76.2 	91.5 	88.6 	90.4 	85.1 	100.7 	98.8
Other non-operating income (expense) 	(218.5) 	(585.7) 	(1,023.3) 	(1,160.6) 	(1,429.9) 	(1,157.1) 	(958.8) 	(964.8) 	(936.9)
Non-operating income (expense) 	139.3 	152.0 	160.1 	168.5 	182.5 	170.3 	155.1 	157.7 	154.8
Income before income taxes 	934.1 	938.7 	904.0 	1,151.4 	1,091.0 	1,059.7 	1,104.9 	1,183.3 	1,212.6
Income taxes 	217.6 	219.6 	206.0 	269.1 	254.6 	241.7 	240.2 	272.2 	280.4
Net income 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1 	932.2
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1 	932.2
Net Income Attributable to Common Shareholders of CME Group 	707.5 	710.0 	689.1 	871.1 	825.9 	807.9 	853.8 	899.7 	920.4
Effective Tax Rate 	23.3% 	23.4% 	22.8% 	23.4% 	23.3% 	22.8% 	21.7% 	23.0% 	23.1%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.97 	1.98 	1.92 	2.43 	2.30 	2.25 	2.38 	2.50 	2.56
Diluted EPS 	1.97 	1.98 	1.92 	2.42 	2.30 	2.25 	2.37 	2.50 	2.56
Weighted average number of common stock shares:
Basic Shares 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258 	359,330
Diluted Shares 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833 	359,869
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --